Evidence map›Paper›PMID 41661434›Full record

ArticleInsights into imaging2026

Primary tumor-derived, multiparametric MRI-based deep learning-radiomics-clinical model for predicting lymph node metastasis in early-stage cervical cancer.

Yu Hao Bao, Yan Chen, Mei Ling Xiao, Yong Ai Li, Feng Hua Ma, Hai Ming Li, Jing Yan Wu, Guo Fu Zhang, Jin Wei Qiang

Abstract read
In one paragraph

Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu Hao BaoDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Yan ChenDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Mei Ling XiaoDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Yong Ai LiDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Feng Hua MaDepartments of Radiology, Obstetrics & Gynecology Hospital, Fudan University, Shanghai, China.
Hai Ming LiDepartment of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jing Yan WuDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Guo Fu ZhangDepartments of Radiology, Obstetrics & Gynecology Hospital, Fudan University, Shanghai, China. guofuzh@fudan.edu.cn.
Jin Wei QiangDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China. dr.jinweiqiang@163.com.ORCID http://orcid.org/0000-0002-6327-1401

Funding

the National Natural Science Foundation of China No.82471943the Shanghai Jinshan District Health Committee No. JSZK2023A02
6 · The paper itself

Abstract

objectivesTo develop and validate a primary tumor-derived, multiparametric MRI-based deep learning-radiomics-clinical (DLRC) model for predicting pelvic lymph node metastasis (LNM) in early-stage cervical cancer. MATERIALS AND

methodsThis retrospective five-center study selected 1095 patients (Jan 2020-Dec 2022), divided into training (n = 481), internal validation (n = 204), and external validation (n = 410) cohorts. Radiomics and deep learning (DL) features were extracted from the volumetric segmentations of the primary cervical tumors on three MRI sequences (CE-T1WI, DWI, FS-T2WI). After constructing individual radiomics and DL models, the DLRC model was developed by integrating the radiomics_score, optimal DL model, and significant clinical features. Model performance was evaluated using ROC analysis, calibration curves, and decision curve analysis.

resultsThe DLRC model demonstrated superior predictive performance, achieving AUCs of 0.807 (95% CI: 0.766-0.849) in the training cohort, 0.789 (95% CI: 0.721-0.857) in the internal validation cohort, and 0.807 (95% CI: 0.761-0.853) in the external validation cohort. It significantly outperformed both the radiomics model and the optimal DL model (all p < 0.001) in the external validation cohort. The calibration curves indicated good agreement between predictions and observations. The decision curve analysis showed that the DLRC model provided the highest net clinical benefit across most decision thresholds.

conclusionsThe DLRC model, which integrates tumor-derived multiparametric MRI features with clinical features, represents a robust and generalizable tool for the preoperative prediction of LNM. Its comparable accuracy to standardized radiological assessment and clinical utility shows potential to aid in personalized treatment planning for patients with early-stage cervical cancer. CRITICAL RELEVANCE STATEMENT: The combined model (DLRC) integrating deep learning and radiomics features from the primary tumor with clinical characteristics enables preoperative LNM risk stratification, supporting personalized surgical planning and reducing unnecessary lymphadenectomy. KEY POINTS: Accurate preoperative prediction of lymph node metastasis in early-stage cervical cancer remains a significant clinical challenge. The model integrating deep learning and radiomics features derived from the primary tumor with clinical features achieved robust and generalizable predictive performance. The accuracy of a deep learning-radiomics-clinical nomogram for lymph node metastasis risk stratification in early-stage cervical cancer is comparable to standardized radiological assessment.

Indexed as

Deep learningLymphatic metastasisMagnetic resonance imagingRadiomicsUterine cervical neoplasms

Identifiers

PMID41661434
PMCPMC12886668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.